GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Gross-Profit-to-Asset %

PharmaTher Holdings (XCNQ:PHRM) Gross-Profit-to-Asset % : 0.00% (As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. PharmaTher Holdings's annualized Gross Profit for the quarter that ended in Feb. 2024 was C$0.00 Mil. PharmaTher Holdings's average Total Assets over the quarter that ended in Feb. 2024 was C$3.24 Mil. Therefore, PharmaTher Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Feb. 2024 was 0.00%.


PharmaTher Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for PharmaTher Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Gross-Profit-to-Asset % Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Gross-Profit-to-Asset %
- - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaTher Holdings's Gross-Profit-to-Asset %

For the Biotechnology subindustry, PharmaTher Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Gross-Profit-to-Asset % falls into.



PharmaTher Holdings Gross-Profit-to-Asset % Calculation

PharmaTher Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in May. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: May. 2023 )/( (Total Assets (A: May. 2022 )+Total Assets (A: May. 2023 ))/ count )
=0/( (12.164+6.31)/ 2 )
=0/9.237
=0.00 %

PharmaTher Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Feb. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Feb. 2024 )/( (Total Assets (Q: Nov. 2023 )+Total Assets (Q: Feb. 2024 ))/ count )
=0/( (3.571+2.914)/ 2 )
=0/3.2425
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Feb. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


PharmaTher Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines